PDF
File
Kurs
-1,36%
Likviditet
0,17 MNOK
Kalender
| Est. tid* | ||
| 2025-10-28 | 19:40 | Kvartalsrapport 2025-Q3 |
| 2025-08-14 | 19:40 | Kvartalsrapport 2025-Q2 |
| 2025-06-05 | N/A | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2025-06-04 | N/A | Årsstämma |
| 2025-04-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-16 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-05 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2024-06-04 | - | Årsstämma |
| 2024-04-30 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-01 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-11 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-02 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2023-06-01 | - | Årsstämma |
| 2023-05-11 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-01 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-12 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2022-06-02 | - | Årsstämma |
| 2022-05-10 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-13 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-04 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2021-06-03 | - | Årsstämma |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-04 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2020-06-03 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-11 | - | Extra Bolagsstämma 2020 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-11-01 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-23 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-29 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2019-05-28 | - | Årsstämma |
| 2019-05-15 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-12-20 | - | Extra Bolagsstämma 2018 |
| 2018-11-09 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-24 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-08 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2018-06-07 | - | Årsstämma |
| 2018-05-30 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-11-10 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-28 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-07 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2017-06-06 | - | Årsstämma |
| 2017-05-10 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2017-01-13 | - | Extra Bolagsstämma 2017 |
| 2016-11-11 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-18 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-21 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2016-06-20 | - | Årsstämma |
| 2016-05-11 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-10-30 | - | Extra Bolagsstämma 2015 |
| 2015-10-30 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-21 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-09 | - | X-dag ordinarie utdelning NAVA 0.00 NOK |
| 2015-06-08 | - | Årsstämma |
| 2015-04-28 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-27 | - | Bokslutskommuniké 2014 |
| 2014-10-31 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-22 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-10 | - | Årsstämma |
| 2014-05-06 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-11-01 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-30 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-05-23 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-15 | - | Bokslutskommuniké 2012 |
| 2012-02-10 | - | Bokslutskommuniké 2011 |
| 2011-10-21 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-25 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-05 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | Årsstämma |
| 2011-02-04 | - | Bokslutskommuniké 2010 |
| 2010-10-28 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-26 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-05 | - | Kvartalsrapport 2010-Q1 |
| 2010-03-25 | - | Årsstämma |
| 2010-02-11 | - | Bokslutskommuniké 2009 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Oslo, 28 April 2023 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, announce that the company has published its Annual Report for 2022, which was approved by the Board of Directors on 27 April 2023.
The report is attached to this notice and is available at navamedic.com/investors. In addition, the company has published its annual financial statements in European Single Electronic Format (ESEF).
"The year 2022 can be summarised by Navamedic successfully delivering on its growth ambition through both acquisitions and new product launches."
For the full year of 2022, revenues amounted to NOK 382.1 million, up 37 per cent compared to 2021. The company's gross margin was 42.8 per cent compared to 40.1 per cent in 2021. Operating profit (EBIT) amounted to NOK 44.4 million compared to NOK 11.5 million in 2021.
"Looking ahead to 2023, we are well underway to achieve our mid-term ambition of operating a NOK 1 billion revenue company with a 15 per cent EBITDA margin. The achievements of 2022 would not have been possible without the dedicated Navamedic team, who have worked incredibly hard to get us to where we are today. I also extend my gratitude to our investors and stakeholders who have supported us along the way. This is an exciting time for the company, and I look forward to keeping you all updated on our achievements as we go," commented Kathrine Gamborg Andreassen, CEO, Navamedic.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, Navamedic
Mobile: +47917 62 842
E-mail: lars.hjarrand@navamedic.com
About Navamedic
Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.